85 related articles for article (PubMed ID: 23758202)
21. Adolescent polycystic ovary syndrome.
Connor EL
Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561
[TBL] [Abstract][Full Text] [Related]
22. [Polycystic ovarian syndrome is a health risk].
Hippeläinen M
Duodecim; 2002; 118(10):981-3. PubMed ID: 12238006
[No Abstract] [Full Text] [Related]
23. Polycystic ovary syndrome: a contemporary view.
Cheung AP; Cog F
J Obstet Gynaecol Can; 2010 May; 32(5):423-425. PubMed ID: 20500948
[No Abstract] [Full Text] [Related]
24. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
25. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
26. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
27. Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome.
Wright CE; Zborowski JV; Talbott EO; McHugh-Pemu K; Youk A
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1026-32. PubMed ID: 15159768
[TBL] [Abstract][Full Text] [Related]
28. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
29. Oligomenorrhoea, polycystic ovary syndrome and recurring miscarriage.
Kumar B; Quenby S; Farquharson R
Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):514-6. PubMed ID: 10193455
[No Abstract] [Full Text] [Related]
30. [Relationship between leptin and insulin sensitivity in patients with polycystic ovary syndrome].
Maliqueo M; Pérez-Bravo F; Calvillán M; Piwonka V; Castillo T; Sir-Petermann T
Med Clin (Barc); 1999 Oct; 113(14):526-30. PubMed ID: 10605667
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome.
Zosmer A
N Engl J Med; 1996 Mar; 334(10):668. PubMed ID: 8592545
[No Abstract] [Full Text] [Related]
32. Pituitary tumors and polycystic ovarian disease.
Futterweit W
Obstet Gynecol; 1983 Sep; 62(3 Suppl):74s-79s. PubMed ID: 6877716
[TBL] [Abstract][Full Text] [Related]
33. Body fat patterning in polycystic ovary syndrome women as a predictor of the response to clomiphene.
Douchi T; Oki T; Yamasaki H; Nakae M; Imabayashi A; Nagata Y
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):838-41. PubMed ID: 15315595
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
35. [Androgenization in patients with polycystic ovary syndrome].
Gasparov AS; Pshenichnikova TIa; Alieva EA; Fedorova TA; Vetr M
Acta Univ Palacki Olomuc Fac Med; 1990; 126():241-6. PubMed ID: 2151091
[TBL] [Abstract][Full Text] [Related]
36. Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index.
Dong Z; Huang J; Huang L; Chen X; Yin Q; Yang D
J Dermatol; 2013 Mar; 40(3):188-92. PubMed ID: 23289590
[TBL] [Abstract][Full Text] [Related]
37. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
Moran LJ; Ranasinha S; Zoungas S; McNaughton SA; Brown WJ; Teede HJ
Hum Reprod; 2013 Aug; 28(8):2276-83. PubMed ID: 23771201
[TBL] [Abstract][Full Text] [Related]
38. [Effect of obesity on nonalcoholic fatty liver disease in Chinese women with polycystic ovary syndrome].
Qu ZY; Shi YH; Zhao DN; Jiang JJ; Ma ZX; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2036-9. PubMed ID: 21029639
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone reduces central obesity in polycystic ovary syndrome women.
Asadipooya K; Kalantar-Hormozi M; Nabipour I
Gynecol Endocrinol; 2012 Jan; 28(1):16-9. PubMed ID: 21756079
[TBL] [Abstract][Full Text] [Related]
40. Polycystic ovary syndrome: 2. Diagnosis and management.
White MC; Turner EI
Br J Hosp Med; 1994 Apr 6-19; 51(7):349-52. PubMed ID: 8081565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
